Tags

Type your tag names separated by a space and hit enter

Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine.
J Pineal Res. 2008 May; 44(4):450-5.JP

Abstract

Irradiation of the melatonin metabolite N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK) with UV light of 254 nm causes the release of carbon monoxide (CO) and, thus, deformylation to N(1)-acetyl-5-methoxykynuramine (AMK). Liberation of CO was demonstrated by reduction of PdCl(2) to metallic palladium, under avoidance of actions by other reductants. Photochemical AMK formation was not due to UV-induced hydroxyl radicals, because the reaction also took place with high efficiency in ethanol and 2-propanol. Moreover, AMK was generated from AFMK by UVB on a dry thin layer chromatographic plate. Although AMK seems to be the major primary product generated by UVB radiation, prolonged exposure of AFMK led to various other products, especially formed by destruction of AMK, as shown by irradiation of this latter compound. With regard to the demonstration of melatonin in skin and substantial amounts of AFMK in keratinocytes, these findings may be of dermatologic relevance.

Authors+Show Affiliations

Johann Friedrich Blumenbach Institute of Zoology and Anthropology, University of Göttingen, Göttingen, Germany.No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18194200

Citation

Seever, Katinka, and Rüdiger Hardeland. "Novel Pathway for N1-acetyl-5-methoxykynuramine: UVB-induced Liberation of Carbon Monoxide From Precursor N1-acetyl-N2-formyl-5-methoxykynuramine." Journal of Pineal Research, vol. 44, no. 4, 2008, pp. 450-5.
Seever K, Hardeland R. Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine. J Pineal Res. 2008;44(4):450-5.
Seever, K., & Hardeland, R. (2008). Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine. Journal of Pineal Research, 44(4), 450-5. https://doi.org/10.1111/j.1600-079X.2007.00550.x
Seever K, Hardeland R. Novel Pathway for N1-acetyl-5-methoxykynuramine: UVB-induced Liberation of Carbon Monoxide From Precursor N1-acetyl-N2-formyl-5-methoxykynuramine. J Pineal Res. 2008;44(4):450-5. PubMed PMID: 18194200.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine. AU - Seever,Katinka, AU - Hardeland,Rüdiger, Y1 - 2008/01/09/ PY - 2008/1/16/pubmed PY - 2008/7/17/medline PY - 2008/1/16/entrez SP - 450 EP - 5 JF - Journal of pineal research JO - J Pineal Res VL - 44 IS - 4 N2 - Irradiation of the melatonin metabolite N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK) with UV light of 254 nm causes the release of carbon monoxide (CO) and, thus, deformylation to N(1)-acetyl-5-methoxykynuramine (AMK). Liberation of CO was demonstrated by reduction of PdCl(2) to metallic palladium, under avoidance of actions by other reductants. Photochemical AMK formation was not due to UV-induced hydroxyl radicals, because the reaction also took place with high efficiency in ethanol and 2-propanol. Moreover, AMK was generated from AFMK by UVB on a dry thin layer chromatographic plate. Although AMK seems to be the major primary product generated by UVB radiation, prolonged exposure of AFMK led to various other products, especially formed by destruction of AMK, as shown by irradiation of this latter compound. With regard to the demonstration of melatonin in skin and substantial amounts of AFMK in keratinocytes, these findings may be of dermatologic relevance. SN - 1600-079X UR - https://www.unboundmedicine.com/medline/citation/18194200/Novel_pathway_for_N1_acetyl_5_methoxykynuramine:_UVB_induced_liberation_of_carbon_monoxide_from_precursor_N1_acetyl_N2_formyl_5_methoxykynuramine_ DB - PRIME DP - Unbound Medicine ER -